Literature DB >> 18487509

Reversible disruption of BCL6 repression complexes by CD40 signaling in normal and malignant B cells.

Jose M Polo1, Weimin Ci, Jonathan D Licht, Ari Melnick.   

Abstract

Germinal center (GC) B cells undergo somatic hypermutation, class switch recombination, and rapid clonal expansion to produce high-affinity antibodies. The BCL6 transcriptional repressor facilitates this phenotype because it can repress DNA damage checkpoint genes. GC B and T cells can make transient direct physical contact; T cells were observed to be associated with dead B-cell fragments. We thus hypothesized that one function of CD40 signaling from T cells within this timeframe could be to modulate BCL6 activity. CD40 signaling rapidly disrupts the ability of BCL6 to recruit the SMRT corepressor complex by excluding it from the nucleus, leading to histone acetylation, RNA polymerase II processivity, and activation of BCL6 target genes, such as CD23b, ATR, and TP53. Washout of CD40 to emulate transient T-cell contact permitted BCL6 target gene mRNA levels to return to their repressed levels, demonstrating that this is a reversible process, which could allow centroblasts that pass quality control to either continue proliferation or undergo terminal differentiation. These data suggest that transient CD40 signaling in the GC might allow T cells to weed out heavily damaged centroblasts while at the same time promoting survival of intact B cells, which could undergo differentiation or additional rounds of proliferation.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18487509      PMCID: PMC2481532          DOI: 10.1182/blood-2008-01-131813

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

1.  BCL-6 expression during B-cell activation.

Authors:  D Allman; A Jain; A Dent; R R Maile; T Selvaggi; M R Kehry; L M Staudt
Journal:  Blood       Date:  1996-06-15       Impact factor: 22.113

2.  The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation.

Authors:  B H Ye; G Cattoretti; Q Shen; J Zhang; N Hawe; R de Waard; C Leung; M Nouri-Shirazi; A Orazi; R S Chaganti; P Rothman; A M Stall; P P Pandolfi; R Dalla-Favera
Journal:  Nat Genet       Date:  1997-06       Impact factor: 38.330

Review 3.  The maturation of the immune response.

Authors:  C Berek; M Ziegner
Journal:  Immunol Today       Date:  1993-08

Review 4.  Signals and signs for lymphocyte responses.

Authors:  C A Janeway; K Bottomly
Journal:  Cell       Date:  1994-01-28       Impact factor: 41.582

5.  CD40 ligation results in protein kinase C-independent activation of ERK and JNK in resting murine splenic B cells.

Authors:  Y Y Li; M Baccam; S B Waters; J E Pessin; G A Bishop; G A Koretzky
Journal:  J Immunol       Date:  1996-08-15       Impact factor: 5.422

6.  Control of inflammation, cytokine expression, and germinal center formation by BCL-6.

Authors:  A L Dent; A L Shaffer; X Yu; D Allman; L M Staudt
Journal:  Science       Date:  1997-04-25       Impact factor: 47.728

7.  The BCL6 proto-oncogene suppresses p53 expression in germinal-centre B cells.

Authors:  Ryan T Phan; Riccardo Dalla-Favera
Journal:  Nature       Date:  2004-12-02       Impact factor: 49.962

8.  Tracking CD40 signaling during germinal center development.

Authors:  Katia Basso; Ulf Klein; Huifeng Niu; Gustavo A Stolovitzky; Yuhai Tu; Andrea Califano; Giorgio Cattoretti; Riccardo Dalla-Favera
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

9.  Direct repression of prdm1 by Bcl-6 inhibits plasmacytic differentiation.

Authors:  Chainarong Tunyaplin; A L Shaffer; Cristina D Angelin-Duclos; Xin Yu; Louis M Staudt; Kathryn L Calame
Journal:  J Immunol       Date:  2004-07-15       Impact factor: 5.422

10.  The Flt3 internal tandem duplication mutant inhibits the function of transcriptional repressors by blocking interactions with SMRT.

Authors:  Shinichiro Takahashi; Melanie J McConnell; Hideo Harigae; Mitsuo Kaku; Takeshi Sasaki; Ari M Melnick; Jonathan D Licht
Journal:  Blood       Date:  2004-02-24       Impact factor: 22.113

View more
  25 in total

1.  CREBBP Inactivation Promotes the Development of HDAC3-Dependent Lymphomas.

Authors:  Yanwen Jiang; Ana Ortega-Molina; Huimin Geng; Hsia-Yuan Ying; Katerina Hatzi; Sara Parsa; Dylan McNally; Ling Wang; Ashley S Doane; Xabier Agirre; Matt Teater; Cem Meydan; Zhuoning Li; David Poloway; Shenqiu Wang; Daisuke Ennishi; David W Scott; Kristy R Stengel; Janice E Kranz; Edward Holson; Sneh Sharma; James W Young; Chi-Shuen Chu; Robert G Roeder; Rita Shaknovich; Scott W Hiebert; Randy D Gascoyne; Wayne Tam; Olivier Elemento; Hans-Guido Wendel; Ari M Melnick
Journal:  Cancer Discov       Date:  2016-10-12       Impact factor: 39.397

2.  Cyclosporine-resistant, Rab27a-independent mobilization of intracellular preformed CD40 ligand mediates antigen-specific T cell help in vitro.

Authors:  Yoshinobu Koguchi; Jennifer L Gardell; Timothy J Thauland; David C Parker
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

Review 3.  The Expanding Role of the BCL6 Oncoprotein as a Cancer Therapeutic Target.

Authors:  Mariano G Cardenas; Erin Oswald; Wenbo Yu; Fengtian Xue; Alexander D MacKerell; Ari M Melnick
Journal:  Clin Cancer Res       Date:  2016-11-23       Impact factor: 12.531

4.  TBL1XR1 Mutations Drive Extranodal Lymphoma by Inducing a Pro-tumorigenic Memory Fate.

Authors:  Leandro Venturutti; Matt Teater; Andrew Zhai; Amy Chadburn; Leena Babiker; Daleum Kim; Wendy Béguelin; Tak C Lee; Youngjun Kim; Christopher R Chin; William T Yewdell; Brian Raught; Jude M Phillip; Yanwen Jiang; Louis M Staudt; Michael R Green; Jayanta Chaudhuri; Olivier Elemento; Pedro Farinha; Andrew P Weng; Michael D Nissen; Christian Steidl; Ryan D Morin; David W Scott; Gilbert G Privé; Ari M Melnick
Journal:  Cell       Date:  2020-07-02       Impact factor: 41.582

5.  CD40L is transferred to antigen-presenting B cells during delivery of T-cell help.

Authors:  Jennifer L Gardell; David C Parker
Journal:  Eur J Immunol       Date:  2016-11-28       Impact factor: 5.532

6.  Phase IA/II, multicentre, open-label study of the CD40 antagonistic monoclonal antibody lucatumumab in adult patients with advanced non-Hodgkin or Hodgkin lymphoma.

Authors:  Michelle Fanale; Sarit Assouline; John Kuruvilla; Philippe Solal-Céligny; Dae S Heo; Gregor Verhoef; Paolo Corradini; Jeremy S Abramson; Fritz Offner; Andreas Engert; Martin J S Dyer; Daniel Carreon; Brett Ewald; Johan Baeck; Anas Younes; Arnold S Freedman
Journal:  Br J Haematol       Date:  2013-11-13       Impact factor: 6.998

7.  SPOP promotes tumorigenesis by acting as a key regulatory hub in kidney cancer.

Authors:  Guoqiang Li; Weimin Ci; Subhradip Karmakar; Ke Chen; Ruby Dhar; Zhixiang Fan; Zhongqiang Guo; Jing Zhang; Yuwen Ke; Lu Wang; Min Zhuang; Shengdi Hu; Xuesong Li; Liqun Zhou; Xianghong Li; Matthew F Calabrese; Edmond R Watson; Sandip M Prasad; Carrie Rinker-Schaeffer; Scott E Eggener; Thomas Stricker; Yong Tian; Brenda A Schulman; Jiang Liu; Kevin P White
Journal:  Cancer Cell       Date:  2014-03-20       Impact factor: 31.743

8.  BCL6 cooperates with CD40 stimulation and loss of p53 function to rapidly transform primary B cells.

Authors:  Saritha Kusam; Veerendra Munugalavadla; Deepali Sawant; Alexander Dent
Journal:  Int J Cancer       Date:  2009-08-15       Impact factor: 7.396

9.  A hybrid mechanism of action for BCL6 in B cells defined by formation of functionally distinct complexes at enhancers and promoters.

Authors:  Katerina Hatzi; Yanwen Jiang; Chuanxin Huang; Francine Garrett-Bakelman; Micah D Gearhart; Eugenia G Giannopoulou; Paul Zumbo; Kevin Kirouac; Srividya Bhaskara; Jose M Polo; Matthias Kormaksson; Alexander D MacKerell; Fengtian Xue; Christopher E Mason; Scott W Hiebert; Gilbert G Prive; Leandro Cerchietti; Vivian J Bardwell; Olivier Elemento; Ari Melnick
Journal:  Cell Rep       Date:  2013-08-01       Impact factor: 9.423

10.  Genome-wide copy-number analyses reveal genomic abnormalities involved in transformation of follicular lymphoma.

Authors:  Alyssa Bouska; Timothy W McKeithan; Karen E Deffenbacher; Cynthia Lachel; George W Wright; Javeed Iqbal; Lynette M Smith; Weiwei Zhang; Can Kucuk; Andrea Rinaldi; Francesco Bertoni; Jude Fitzgibbon; Kai Fu; Dennis D Weisenburger; Timothy C Greiner; Bhavana J Dave; Randy D Gascoyne; Andreas Rosenwald; German Ott; Elias Campo; Lisa M Rimsza; Jan Delabie; Elaine S Jaffe; Rita M Braziel; Joseph M Connors; Louis M Staudt; Wing-Chung Chan
Journal:  Blood       Date:  2013-09-13       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.